Selectivity of C3-opsonin targeted complement inhibitors: a distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients

  1. Lookup NU author(s)
  2. Dr Kevin Marchbank
Author(s)Schmidt CQ, Harder M, Nichols E, Hebecker M, Anliker M, Höchsmann B, Simmet T, Csincsi ÁI, Uzonyi B, Pappworth IY, Ricklin D, Lambris JD, Schrezenmeier H, Józsi M, Marchbank KJ
Publication type Article
JournalImmunobiology
Year2016
Volume221
Issue4
Pages503-511
ISSN (print)0171-2985
ISSN (electronic)1878-3279
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherElsevier
URLhttp://dx.doi.org/10.1016/j.imbio.2015.12.009
DOI10.1016/j.imbio.2015.12.009
PubMed id26792457
Actions    Link to this publication

Altmetrics provided by Altmetric

Share